HPV and Male Homosexuality in General Practice?

HPV Vaccination (Human Papilloma Virus), or How to Address Male Homosexuality in General Practice in Alsace?

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05078554

Acronym

HPV

Enrollment

Registered

2021-10-14

Start date

2021-05-27

Completion date

2022-01-27

Last updated

2022-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Papilloma Viral Infection

Keywords

Papilloma Viral Infection, HPV, HPV vaccine

Brief summary

The main objective of this study is to find out whether young MSM (men who have sex with men) believe it is important for their GP to be informed of their sexual orientation, in order to improve their clinical, especially with HPV vaccination. The secondary objective is to analyze the state of knowledge about the HPV vaccine and the value of HPV vaccine in this target population.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

MALE

Age

18 Years to 26 Years

Inclusion criteria

* Age: 18-26 years * Consultation at the HUS Cegidd as part of an STI screening * Subject who expressed no opposition to participating in the study

Exclusion criteria

* Refusal of the patient to participate in the study * Subject who had already benefited from HPV vaccination (at least one dose) * Inability to give informed consent * Subject under safeguarde of justice * Subject under guardianship or under curatorship

Design outcomes

Primary

Measure	Time frame
Retrospective descriptive study of vaccination against HPV (Human Papilloma Virus) in Alsace?	Files analysed retrospectively from April 27, 2021 to January 27, 2020 will be examined]

Countries

France

Outcome results